From Surf Wiki (app.surf) — the open knowledge base

Eptazocine

Opioid analgesic

72150-17-5 (bromide) | elimination_half-life =

Eptazocine (Sedapain) is an opioid analgesic which was introduced in Japan by Morishita in 1987. It acts as a mixed κ-opioid receptor agonist and μ-opioid receptor antagonist.

References

(2000). "Index nominum 2000: international drug directory". Taylor & Francis US.
American Chemical Society. Division of Medicinal Chemistry. (1990). "Annual Reports in Medicinal Chemistry". Academic Press.
(May 1985). "The interaction of eptazocine, a novel analgesic, with opioid receptors". Research Communications in Chemical Pathology and Pharmacology.
(21 January 2011). "Chemistry of Opioids". Springer.
(January 1990). "[Preferential action of eptazocine, a novel analgesic, with opioid receptors in isolated guinea pig ileum and mouse vas deferens preparations]". Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica.
(1999). "Concise dictionary of pharmacological agents: properties and synonyms". Springer.

Info: Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

hydroxyarenes opioids

Want to explore this topic further?

Ask Mako anything about Eptazocine — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report